NR4A1 and neoplasm: Tumour size (HR: 1.99, P < 0.005), nodal involvement (HR: 1.89, P = 0.01) and age (HR: 1.09, P < 0.005) remained associated with poorer overall survival (Table 2) whereas hormone receptor positivity was associated with improved overall survival (HR: 0.47, P = 0.04).